Miscellaneous

Trial A Phase I trial of LY3143921 hydrate in solid tumours
Cancer Type Miscellaneous and Non-specific
Hospital(s) Belfast City Hospital
Information

A Cancer Research UK phase I trial of LY3143921 hydrate (a CDC7 inhibitor) given orally once daily in adult patients with advanced solid tumours

Trial Add-Aspirin Trial
Cancer Type Bowel Cancer, Gastrointestinal, Genitourinary, Miscellaneous, Oesophageal Cancer, Prostate Cancer, Stomach Cancer, and Non-specific
Hospital(s) Belfast City Hospital
Information

A Phase III, Double-Blind, Placebo-Controlled Randomised Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival after Primary Therapy in Common Non-Metastatic Solid Tumours

Click Here to view CancerHelpUK trial summary
Trial CellCentric
Cancer Type Miscellaneous and Non-specific
Hospital(s) Belfast City Hospital
Information

An open-label Phase I/IIa study to evaluate the safety and efficacy of CCS1477 as monotherapy and in combination in patients with advanced solid/metastatic tumours

Trial DIAdIC
Cancer Type Miscellaneous and Non-specific
Hospital(s) Belfast City Hospital
Information

Protocol for an International Randomized Controlled Trial to evaluate the effectiveness of a nurse-delivered (FOCUS+) and a web-based (iFOCUS) psychoeducational intervention for people with Advanced cancer and their family caregivers

Trial FAK-PD1
Cancer Type Miscellaneous and Non-specific
Hospital(s) Belfast City Hospital
Information

A Phase I/IIA Study to Assess Safety, Tolerability and Preliminary Activity of FAK (defactinib) and PD-1 (Pembrolizumab) Inhibition in Patients with Advanced Solid Malignancies

Click Here to view CancerHelpUK trial summary
Trial TOASTIE
Cancer Type Miscellaneous
Hospital(s) Belfast City Hospital
Information

Tolerance Of Anti-cancer Systemic Therapy In the Elderly

Trial UK P3BEP
Cancer Type Genitourinary and Miscellaneous
Hospital(s) Belfast City Hospital
Information

A randomized phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours

Click Here to view CancerHelpUK trial summary